BIOCENTRE

BIOCENTRE has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €226,775 and a net result of €40,683, of which €70,345 non-recurring income. Equity is growing by about 11% per year across the filed financial years. Its solvency ranks better than 50% of 5,027 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).